NLS Pharmaceutics (NLSP) provided insights into the preclinical program evaluating its dual orexin receptor agonist platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed ...
Last Wednesday, Acclaim EmpireX represented the Philippines for the first time at the King of Sea Tournament, where they faced the Saigon Jokers, reigning champions of the Garena Premiere League. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback